Intensity Therapeutics, Inc.
INTS
$4.04
$0.020.50%
NASDAQ
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -6.01% | -18.74% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 22.09% | -19.55% | |||
| Operating Income | -22.09% | 19.55% | |||
| Income Before Tax | -23.54% | 20.22% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -23.54% | 20.22% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -23.54% | 20.22% | |||
| EBIT | -22.09% | 19.55% | |||
| EBITDA | -- | -- | |||
| EPS Basic | -15.66% | 26.64% | |||
| Normalized Basic EPS | -15.66% | 26.65% | |||
| EPS Diluted | -15.66% | 63.35% | |||
| Normalized Diluted EPS | -15.66% | 26.65% | |||
| Average Basic Shares Outstanding | 6.82% | 8.76% | |||
| Average Diluted Shares Outstanding | 6.82% | 8.76% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||